Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Blood
|
June 10, 2010
HS1 has a central role in the trafficking and homing of leukemic B cells
Cristina Scielzo, Maria T S Bertilaccio, Giorgia Simonetti, et al.
Cancer Immunology Research
|
July 19, 2019
SLAMF6 as a Regulator of Exhausted CD8<sup>+</sup> T Cells in Cancer
Burcu Yigit, Ninghai Wang, Elisa Ten Hacken, et al.
Genome Biology
|
October 21, 2020
High throughput single-cell detection of multiplex CRISPR-edited gene modifications
Elisa Ten Hacken, Kendell Clement, Shuqiang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2016
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
Candida Vitale, Lorenzo Falchi, Elisa Ten Hacken, et al.
Haematologica
|
July 29, 2017
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia
Elisa ten Hacken, Maria Gounari, Jaap Willem Back, et al.
JCI Insight
|
July 22, 2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway
Bo Zhang, Prajish Iyer, Meiling Jin, et al.
Blood
|
January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment
Roberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Nature Medicine
|
May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Nature Medicine
|
February 25, 2026
Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Leukemia
|
January 25, 2020
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Miguel Quijada-Álamo, María Hernández-Sánchez, Verónica Alonso-Pérez, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Blood
|
June 10, 2010
HS1 has a central role in the trafficking and homing of leukemic B cells
Cristina Scielzo, Maria T S Bertilaccio, Giorgia Simonetti, et al.
Cancer Immunology Research
|
July 19, 2019
SLAMF6 as a Regulator of Exhausted CD8<sup>+</sup> T Cells in Cancer
Burcu Yigit, Ninghai Wang, Elisa Ten Hacken, et al.
Genome Biology
|
October 21, 2020
High throughput single-cell detection of multiplex CRISPR-edited gene modifications
Elisa Ten Hacken, Kendell Clement, Shuqiang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2016
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
Candida Vitale, Lorenzo Falchi, Elisa Ten Hacken, et al.
Haematologica
|
July 29, 2017
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia
Elisa ten Hacken, Maria Gounari, Jaap Willem Back, et al.
JCI Insight
|
July 22, 2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway
Bo Zhang, Prajish Iyer, Meiling Jin, et al.
Blood
|
January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment
Roberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Nature Medicine
|
May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Nature Medicine
|
February 25, 2026
Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Leukemia
|
January 25, 2020
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Miguel Quijada-Álamo, María Hernández-Sánchez, Verónica Alonso-Pérez, et al.
Page
of 5